$PIRS
Pieris Pharmaceuticals Inc
PRICE
$2.005 โฒ6.952%
Last Close
VOLUME
207,568
DAY RANGE
1.85 - 2.01
52 WEEK
1.54 - 6.15
Join Discuss about PIRS with like-minded investors
@TraderXx #StockTraders.NET
$VTNR same opening as with $PIRS yday, watchout
64 Replies 14 ๐ 7 ๐ฅ
Key Metrics
Market Cap
148.20 M
Beta
1.13
Avg. Volume
300.22 K
Shares Outstanding
74.10 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Pieris Pharmaceuticals Inc.is a clinical-stage biotechnology company that discovers and develops Anticalin protein-based drugs to target validated disease pathways in a unique and transformative way. Its pipeline includes inhalable Anticalin proteins to treat respiratory diseases and immuno-oncology multi-specifics tailored for the tumor microenvironment. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Anticalinยฎ is a registered trademark of Pieris.
CEO: Stephen Yoder
Website: www.pieris.com
HQ: 255 State St Fl 9 Boston, 02109-2615 Massachusetts
Related News